TECENTRIQ vs ZELBORAF

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. TECENTRIQ and ZELBORAF are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	TECENTRIQ	ZELBORAF
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ATEZOLIZUMAB	VEMURAFENIB
Manufacturer	Genentech Inc	Hoffmann La Roche
Dosage forms	Injectable	Tablet
Drug class	—	—
Boxed warning	None	None
Treats	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma	Melanoma

tecentriq zelboraf

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

ATEZOLIZUMAB

VEMURAFENIB

Manufacturer

Genentech Inc

Hoffmann La Roche

Dosage forms

Injectable

Tablet

Drug class

—

Boxed warning

None

Treats

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

Melanoma

Frequently asked questions

What is the difference between Tecentriq and Zelboraf?

Tecentriq contains Atezolizumab, while Zelboraf contains Vemurafenib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.